All posts tagged pharmaceuticals


How much influence does the pharmaceutical industry have on the British economy?

It is no exaggeration to say that the UK economy has been in the doldrums over the last few years, with companies in many industries struggling to get by. But a recessionary environment can often lead to the biggest contributors […]

Continue Reading...

Irish biotech group Elan puts itself on the block after advising against hostile bid from RP Management

Irish biotechnology firm Elan Corp plc (NYSE:ELN) said it was launching a formal sale given expressions of interest it had received and would invite hostile suitor RP Management


Pharmaceuticals firm Novartis denies talk on bid for generic drug maker Actavis

Swiss pharma major Novartis AG (VTX:NOVN) does not intend to pursue a takeover of US drugmaker Actavis Inc (NYSE:ACT), a company spokesperson told Reuters, refuting a previous report

Pharmaceutical manufacturing

Actavis says discusses merger with Warner Chilcott

US speciality pharmaceutical company Actavis Inc (NYSE:ACT) said it had engaged in early-stage talks to potentially combine with Irish sector player Warner Chilcott plc (NASDAQ:WCRX). The US firm noted

Pharmaceutical manufacturing

Pharmaceuticals giant GSK increase stake in Indian healthcare unit to 73%

UK drug maker GlaxoSmithKline Plc (LON:GSK) said today it had increased its stake in its Indian unit GlaxoSmithKline Consumer Healthcare Ltd to 72.5% from 43.2%, as part


Irish pharmaceutical firm Warner Chilcott ends talks with possible buyers

Dublin-based speciality pharmaceuticals group Warner Chilcott plc (NASDAQ:WCRX) said it had terminated talks with potential buyers and decided instead to pursue other alternatives to boost shareholder value. At the

Pharmaceutical manufacturing

British drugs giant GSK could announce a deal for HGS today

British drugmaker GlaxoSmithKline Plc (LON:GSK) is seen to increase to some USD14.00 (EUR11.43) a share, or around USD2.8bn in total, from USD13.00 per share, its bid to buy


Genova Diagnostics buys Metametrix

US diagnostic testing specialist Genova Diagnostics Inc said it had acquired clinical laboratory tests provider Metametrix Inc for an undisclosed sum. Following the transaction, Metametrix's chief executive officer Dr


Human Genome recommends stockholders reject GSK’s bid

US biopharmaceutical firm Human Genome Sciences (NASDAQ:HGSI), or HGS, reiterated its advice to shareholders not to tender their stock to the $13.00 (EUR10.30) a share hostile takeover offer


Bristol-Myers Squibb agrees $5.3bn deal to acquire Amylin

US pharmaceutical group Bristol-Myers Squibb Co (NYSE:BMY) said it had made an agreement to buy diabetes-focused biopharmaceutical firm Amylin Pharmaceuticals Inc (NASDAQ:AMLN) at U$31.00 (€24.50) in cash per

Powered by WordPress